COVID-19 Updates
COVID-19 News
Leveraging the Million Veteran Program Infrastructure and Data for a Rapid Research Response to COVID-19
The Million Veteran Program (MVP) was launched in 2011 by the US Department of Veterans Affairs (VA) to enroll at least 1 million veterans in a...
COVID-19 News
VA Lessons From Partnering in COVID-19 Clinical Trials
The US Department of Veterans Affairs (VA), through its Office of Research and Development (ORD), supports an extensive and experienced clinical...
COVID-19 News
The VA Research Enterprise: A Platform for National Partnerships Toward Evidence Building and Scientific Innovation
The US Department of Veterans Affairs (VA) plays a substantial role in the nation’s public health through the Veterans Health Administration (VHA...
Commentary
Introduction
Like the flip of a light switch, the world in March 2020 went into lockdown. Suddenly the novel coronavirus disease (COVID-19) was ever-present...
Commentary
Foreword: VA Research and COVID-19
The impressive collection of articles in this special issue provides a snapshot of the large-scale, all-hands approach the VHA adopted during the...
News
COVID, no matter the severity, linked with urologic effects in men
“Clinicians should be aware of the significantly higher incidence of [lower urinary tract infection] complications with COVID-19 in this patient...
Commentary
Don’t fear POTS: Tips for diagnosis and treatment
Sometimes that combination of a heart rate-lowering medication and a medication that increases blood pressure really works well.
News
Study: Unexpected vaginal bleeding rises after COVID vaccination
Researchers suggested it could have been connected to the SARS-CoV-2 spike protein in the vaccines.
News
Study: Antiviral med linked to COVID mutations that can spread
“There aren’t any widely circulating variants that have the signature. At the moment there’s nothing that’s transmitted very widely that’s due to...
News
Paxlovid weaker against current COVID-19 variants
But when looking at death alone, the antiviral was still highly effective.